이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Divi's Laboratories 대차 대조표 상태

재무 상태 기준 확인 6/6

Divi's Laboratories 의 총 주주 지분은 ₹126.8B 이고 총 부채는 ₹50.0M, 이는 부채 대 자기자본 비율을 0.04% 로 가져옵니다. 총자산과 총부채는 각각 ₹142.8B 및 ₹16.1B 입니다. Divi's Laboratories 의 EBIT는 ₹15.9B 이며 이자보상배율은 -7.8 입니다. ₹36.1B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

부채 비율

₹0

부채

이자 보상 비율	609x
현금	₹39.80b
주식	₹135.71b
총 부채	₹18.99b
총 자산	₹154.70b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Apr 19

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 21

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Jul 07

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Jul 03

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Apr 03

Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?

Dec 23

With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting

Sep 02

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching

Mar 25

Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Mar 10

Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?

Feb 23

Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?

Jan 25

재무 상태 분석

단기부채: DIVISLAB 의 단기 자산 ( ₹88.8B )이 단기 부채( ₹10.1B ).

장기 부채: DIVISLAB 의 단기 자산( ₹88.8B )이 장기 부채( ₹6.0B ).

부채 대 자본 내역 및 분석

부채 수준: DIVISLAB 부채가 없습니다.

부채 감소: DIVISLAB 는) 부채 대 자기자본 비율이 1.5% 였던 5년 전과 비교하여 부채가 없습니다.

부채 범위: DIVISLAB 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: DIVISLAB 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

Divi's Laboratories 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Divi's Laboratories Limited Announces Board and Committee Changes

Insider recently sold ₹46m worth of stock

Insider recently sold ₹238m worth of stock

Dividend of ₹30.00 announced

Price target increased by 11% to ₹3,806

Divi's Laboratories Limited Recommends A Final Dividend for the Financial Year 2023-24

Divi's Laboratories Limited to Report Q4, 2024 Results on May 25, 2024

Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price

Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)

Insider recently sold ₹24m worth of stock

Chief Technologist recently sold ₹56m worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q3, 2024 Results on Feb 10, 2024

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar

Non-Executive Independent Director recently sold ₹1.4m worth of stock

Consensus EPS estimates fall by 10%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently sold ₹3.3m worth of stock

Chief Technologist recently sold ₹2.9m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2023

Divi's Laboratories Limited Informs Resignations of Directors

Price target increased by 7.3% to ₹3,325

New minor risk - Profit margin trend

Insufficient new directors

Divi's Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₹30.00 per share at 0.8% yield

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00

New minor risk - Insider selling

Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00

Divi's Laboratories Limited, Annual General Meeting, Aug 28, 2023

Insider recently sold ₹3.4m worth of stock

Divi's Laboratories Limited Recommends a Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹68.69 (vs ₹112 in FY 2022)

Divi's Laboratories Limited to Report Q4, 2023 Results on May 20, 2023

Insider recently sold ₹2.0m worth of stock

Global Quality Head recently sold ₹2.3m worth of stock

Global Quality Head recently sold ₹2.8m worth of stock

Global Quality Head recently sold ₹28m worth of stock

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 15%

Divi's Laboratories Limited to Report Q3, 2023 Results on Feb 03, 2023

Board Member recently sold ₹10m worth of stock

MD & Executive Director recently sold ₹1.0m worth of stock

Insider recently sold ₹1.7m worth of stock

Insider recently sold ₹1.2m worth of stock

Consensus EPS estimates fall by 12%

Price target decreased to ₹3,582

Price target decreased to ₹3,685

Price target decreased to ₹3,685

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?

Insider recently sold ₹1.5m worth of stock

Insider recently sold ₹3.7m worth of stock

Upcoming dividend of ₹30.00 per share

Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00

Divi's Laboratories Limited to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year

Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00

Divi's Laboratories Limited Recommends Dividend

Divi's Laboratories Limited, Annual General Meeting, Aug 22, 2022

Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today

Insider recently sold ₹2.5m worth of stock

Insider recently sold ₹7.3m worth of stock

Divi's Laboratories Limited Recommends A Dividend for the Year 2021-2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories Limited to Report Q4, 2022 Results on May 23, 2022

Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?

Insider recently sold ₹2.7m worth of stock

Board Member recently sold ₹21m worth of stock

Insider recently bought ₹796k worth of stock